Payments to Acquire Property, Plant, and Equipment of Sage Therapeutics, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Sage Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Sage Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $0, a 100% decline year-over-year.
  • Sage Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $0, a 100% decline from 2023.
  • Sage Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $553,000, a 41% decline from 2022.
  • Sage Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $937,000, a 152% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Sage Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 -$553,000 -100% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2025 2024 FY
2023 $553,000 -$384,000 -41% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2025 2024 FY
2022 $937,000 +$565,000 +152% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
2021 $372,000 +$27,000 +7.8% 01 Jan 2021 31 Dec 2021 10-K 14 Feb 2024 2023 FY
2020 $345,000 -$5,406,000 -94% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $5,751,000 +$2,891,000 +101% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $2,860,000 +$1,500,000 +110% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $1,360,000 -$61,000 -4.3% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $1,421,000 +$1,223,000 +618% 01 Jan 2016 31 Dec 2016 10-K 19 Feb 2019 2018 FY
2015 $198,000 +$70,000 +55% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
2014 $128,000 +$125,000 +4167% 01 Jan 2014 31 Dec 2014 10-K 24 Feb 2017 2016 FY
2013 $3,000 -$108,000 -97% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $111,000 01 Jan 2012 31 Dec 2012 10-K 06 Mar 2015 2014 FY

Sage Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 -$225,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 25 Apr 2024 2024 Q1
Q1 2023 $225,000 +$56,000 +33% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q1 2022 $169,000 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q1 2020 $276,000 -$981,000 -78% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $1,257,000 +$605,000 +93% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $652,000 +$407,000 +166% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $245,000 -$96,000 -28% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $341,000 +$231,000 +210% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $110,000 +$107,000 +3567% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q1 2014 $3,000 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.